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A major difficulty in the analysis of complex biological systems is dealing with the low signal-
to-noise inherent to nearly all large biological datasets. We discuss powerful bioinformatic
concepts for boosting signal-to-noise through external knowledge incorporated in processing units
we call filters and integrators. These concepts are illustrated in four landmark studies that have
provided model implementations of filters, integrators, or both.Introduction
Complexity is the grand challenge for science and engineering in
the 21st century. Complex systems—by definition—have many
parts in an intricate arrangement that gives rise to seemingly
inexplicable or emergent behaviors. For example, a radio
captures an electromagnetic signal and converts it through elec-
tronic circuitry into sound that we hear. To most, the radio is
a black box with an input (electromagnetic waves) and an output
(sound waves). However, understanding the inner workings of
this box requires going head-to-head with the challenges of
complexity. What are the component parts of the system and
how are these parts interconnected? How do these connections
influence functions and dynamic system outputs? In biology,
ultimately one would like to create models that predict the
emergent behaviors of complex entities—and even re-engineer
these behaviors to humankind’s benefit.
To decipher complexity, biologists have developed an
impressive array of technologies—next-generation sequencing,
tandem mass spectrometry, cell-based screening, and so on—
that are capable of generating millions of molecular measure-
ments in a single run. This enormous amount of data, however,
is typically accompanied by a fundamental problem—an incred-
ibly low rate of signal-to-noise. For example, the millions of
single-nucleotide variants (SNVs) found in a typical genome-
wide association study or by the International Cancer Genome
Consortium (Hudson et al., 2010) make it extremely difficult to
identify which particular SNVs are the true causes of disease.
Due to the overwhelming number of measurements, such anal-
yses either lack power to detect the true signal or must admit
an unacceptable amount of noise.
Fortunately, biologists have two major weapons with which
signal-to-noise may be improved. First is what we know about
complexity, which can and should be used as strong prior
assumptions when analyzing biological data. Known principles
of complexity such as modularity, hierarchical organization,
evolution, and inheritance (Hartwell et al., 1999) all provide860 Cell 144, March 18, 2011 ª2011 Elsevier Inc.important insights into how biological systems are constructed
and how they function. Second is the availability of data in
many complementary layers—including the genome, transcrip-
tome, proteome, metabolome, and interactome. A recent wave
of new bioinformatic methods has demonstrated how both
weapons—strong prior assumptions related to complexity and
systematic accumulation of complementary data—can be
used together or separately to exact substantial increases in
signal-to-noise.
In what follows, we summarize these developments within
a general paradigm for signal detection in biology. Central to
this paradigm are processing units we call filters and integrators,
which draw on prior biological assumptions and complementary
data to reduce noise and to boost statistical power. To illustrate
these ideas in context, we review four landmark studies that have
provided model implementations of filters and integrators.
The Signal Detection Paradigm
Imagine a biological dataset as a stream of information flowing
into a hypothetical signal detection device (Figure 1A). The infor-
mation flow is quantized into atomic units or events, representing
measurements for entities such as genes or proteins, protein
interactions, SNVs, pathways, cells, or individuals. Each event
contains a certain amount of information, ranging from a single
measurement (e.g., strength of protein interaction) to thousands
(e.g., an SNV state or gene expression value over a population of
patients). Some events represent true biological signals, with the
definition of ‘‘signal’’ depending exquisitely on the type of results
the experimentalist is looking for (e.g., an SNV causing disease
or a true protein interaction; many examples are given later).
The remaining events are noise, which can be due to errors
that are technical in nature (uncontrollable variation in different
instrument readings collected from the same sample) or biolog-
ical in nature (uncontrollable variation in different samples
collected from the same biological condition). An event may
also be considered part of noise even if it is biological and
Figure 1. Boosting Signal-to-Noise in Biological Data using Prior
Knowledge
(A) Signal detection paradigm in which an input data stream is routed through
a series of filtering and integration units, ending in a statistical test that makes
accept or reject decisions. Symbols:m, information per event or sample size;
D, effect size; ta, decision threshold; FDR, false discovery rate.
(B) Probability distribution P(t) of the test statistic t over the entire data stream
of signal plus noise (purple). This distribution is factored into a red signal and
a blue noise component. FDR and power are visualized in terms of the areas
under these curves to the right of ta.
(C) Effect of varying parameters on the signal, noise, and signal plus noise
probability distributions. The power is increased by more than 6-fold
compared to (B), at an identical FDR. Colors are shown as in (B).
(D) MAGENTA, a specific implementation of the signal detection paradigm for
pathway-based disease gene mapping as described in Segre` et al. (2010).reproducible, simply because it encodes aspects of phenotype
irrelevant to the current studies.
To make a decision on which events are signal, the device
scores each event and accepts those for which the score
exceeds a statistically defined decision threshold (Figure 1A). It
is precisely this decision that becomes problematic in many
large-scale biological studies, in which one either mistakenly
rejects a large proportion of the true signal (low statistical power)
or must tolerate a high proportion of accepted events that are
noise (high false discovery rate or FDR).Boosting Signal with Filters and Integrators
To increase signal-to-noise, a pivotal trend in bioinformatics has
been to augment the signal detection process with complemen-
tary datasets andwith prior knowledge about the nature of signal.
The vast majority of these approaches fall into either of two cate-
gories that we call filters and integrators (Table S1 available
online). Filters attempt to cull some events from the information
flow immediately and reject them as noise. For example, a detec-
tion system for differential expression might reject certain genes
immediately if their expression levels fail to exceed a background
value in any condition. Integrators, on the other hand, transform
the information flow by aggregating individual events into larger
units to yield a fundamentally new type of information, or by inte-
grating together different types of information (Hwang et al.,
2009). For example, genes might be aggregated into clusters of
similar expression or of related function, in which the median
levels of the clusters—not their individual genes—are propa-
gated as the ‘‘events’’ on which final accept/reject decisions
are made (Park et al., 2007). Importantly, the combining of filters
or integrators results in a new device that itself can be recom-
bined with other signal detection systems in a modular fashion.
Both filters and integrators influence statistical power and
FDR, but by fundamentally different means. Filters reduce the
fraction of noise passing through the system and, as a conse-
quence, the FDR. Alternatively, as filters are added, FDR can
be held constant by relaxing the decision threshold, resulting in
higher statistical power (Figures 1B and 1C). By comparison,
integrators combine a train of weak signals into fewer stronger
events, leading to an increase in ‘‘effect size’’ and thus a direct
increase in statistical power. These methods complement the
more classical means of boosting power by increasing the
amount of information per event (also called the sample size)
(Figure 1A).
In each of the following four examples, boosting power with
a combination of filters and integrators has been critical to the
success of a landmark genome-scale analysis project.
Example 1: Pathway-Level Integration of Genome-wide
Association Studies
Genome-wide association studies (GWAS) seek to identify
polymorphisms, such as SNVs, that cause a disease or other
phenotypic trait of interest. Despite the success of this strategy
in mapping SNVs underlying many diseases, the identified loci
typically explain only a small proportion of the heritable variation.
For such diseases, one likely explanation is that the genetic
contribution is distributed over many functionally related loci
with large collective impact but with only modest individual
effects that do not reach genome-wide significance in single-
SNV tests (Wang et al., 2010; Yang et al., 2010).
Based on this hypothesis, Segre` et al. (2010) investigated the
collective impact of mitochondrial gene variation in type II dia-
betes. They described amethod called MAGENTA that performs
a meta-analysis of many different GWAS to achieve larger
sample sizes than any single study, thereby increasing statistical
power. MAGENTA also includes both filtering and integration
steps (Figure 1D). First, a filter is applied so that SNVs that fall
far from genes are removed. Next an integrator is applied to
transform SNVs to genes, such that each gene is assigned aCell 144, March 18, 2011 ª2011 Elsevier Inc. 861
score equal to the most significant p value of association among
its SNVs. Gene scores are further corrected for confounding
factors such as gene size, number of SNVs per kilobase, and
genetic linkage. Finally, a second integrator combines the scores
across sets of genes assigned to the same biochemical function
or pathway, resulting in a single pathway-level p value of associ-
ation.
Simulation studies using MAGENTA suggest a potentially
large boost in power to detect disease associations
(Figure S1A). For example, the method has 50% power to detect
enrichment for a pathway containing 100 genes of which 10
genes have weak association to the trait of interest. This perfor-
mance is compared to only 10% power to detect any of the 10
genes at the single-SNV level. At this increased power,
MAGENTA did not identify any mitochondrial pathways as func-
tionally associated with type II diabetes, suggesting that mito-
chondria have overall low genetic contribution to diabetes
susceptibility—a surprise given the conventional wisdom about
the disease. On the other hand, in an independent analysis of
genes influencing cholesterol, MAGENTA identified pathways
related to fatty acid metabolism that had been missed by clas-
sical GWAS.
Example 2: Mapping Disease Genes in Complete
Genomes
Sequencing and analysis of individual human genomes is one of
the most exciting emerging areas of biology, made possible by
the rapid advances in next-generation sequencing (Metzker,
2010). As complete genome sequencing becomes pervasive,
one of the most important challenges will be to determine how
such sequences should best be analyzed to map disease genes.
Thesignal filteringand integrationparadigmprovidesanexcellent
framework for developing methods in this arena. As a landmark
example, Roach et al. (2010) described a filtering methodology
for disease genes based on the complete genomic sequences
of a nuclear family of four. This approach was used to identify
just three candidate mutant genes, one of which encoded the
Miller syndrome, a rare recessive Mendelian disorder for which
both offspring, but neither parent, were affected.
To begin the analysis, the four genome sequences were
processed to identify approximately 3.7 million SNVs across
the family. SNVs were then directed through a series of filters
(Figure S2A). In the first, SNVs were rejected if they were unlikely
to influence a gene-coding region annotated in the human
genome reference map (http://genome.ucsc.edu/), leaving
approximately 1% of SNVs that led to missense or nonsense
mutations or fell precisely onto splice junctions. A second filter
removed SNVs that were common in the human population
and thus were unlikely to cause a rare Mendelian disorder. Like
the first one, this filter yielded an approximate 100-fold decrease
in the number of candidates. A third filter was designed to check
inheritance patterns, which can be gleaned only from a family of
related genomes. SNVswere removed that had a non-Mendelian
pattern of inheritance (result of DNA sequencing errors) or did not
segregate as expected for a recessive disease gene, in which
each affected child must inherit recessive alleles from both
parents. This filter yielded another 4- to 5-fold decrease in candi-
date SNVs versus using only a single parental genome. Finally,862 Cell 144, March 18, 2011 ª2011 Elsevier Inc.an integrator was used to translate all remaining SNVs into their
corresponding genes.
Using the entire system of filters and integrators under
a compound heterozygote recessive model, a total of three
genes were identified as candidates. One of these (DHODH)
was concurrently shown to be the cause of Miller syndrome.
In this way, the family genome sequencing approach used the
principles of Mendelian genetics (prior knowledge) to correct
approximately 70% of the sequencing errors, directly identify
rare variants (those present in two or more family members),
and reduce enormously the search space for disease traits (cor-
responding to an increase in statistical power from 0.15% to
33%) (Figure S1B).
Example 3: Assembly of Global Protein Signaling
Networks
Another area in which filtering and integration are turning out to
be key is assembly of protein networks. An excellent example
of network assembly is providedby the recentwork of Breitkreutz
et al. (2010), in which mass spectrometric analysis was used to
report a high-quality network of 1844 interactions centered on
yeast kinases and phosphatases. Central to the task of network
assembly was a signal detection system for quality control and
interpretation of the raw data. The data consisted of a stream
of more than 38,000 proteins that had been coimmunoprecipi-
tated with a different kinase or phosphatase used as bait. Bait
proteins can interact both specifically and nonspecifically with
a wide variety of peptides, and the nonspecific interactions
comprise a major source of noise. To remove nonspecific inter-
actions, the authors introduced a method called significance
analysis of interactome (SAINT), in which each putative interact-
ing protein is assigned a likelihood of true interaction based on its
number of peptide identifications (representing the amount of
information per event or sample size) (Figure S2B). After filtering,
the remaining protein interactors are funneled to an integrator
stage in which they are clustered into modules based on their
overall pattern of interactions (Table S1).
The resulting modular interaction network reveals an unprece-
dented level of crosstalk between kinase and phosphatase units
during cell signaling. In this network, kinases and phosphatases
are not mere cascades of proteins ordered in a linear fashion.
Rather, they are more akin to the neurons of a vast neural
network, in which each kinase integrates signals from myriad
others, enabling the network to sense cell states, compute func-
tions of these states, and drive an appropriate cellular response.
It is likely that evolution tunes this network, such that some inter-
actions dominate and others are minimized in a species-specific
fashion. This might help explain two paradoxical effects seen
pervasively in both signaling and regulation: (1) the same
network across species can be used to control very different
phenotypes (McGary et al., 2010); and (2) very different networks
across species can be used to execute near identical responses
(Erwin and Davidson, 2009).
Example 4: Filtering Gene Regulatory Networks
using Prior Knowledge
One of the grand challenges of biology is to decipher the
networks of transcription factors and other regulatory
components that drive gene expression, phenotypic traits, and
complex behaviors (Bonneau et al., 2007). Toward this goal,
probabilistic frameworks such as Bayesian networks have
been extensively applied to learn gene regulatory relationships
from mRNA expression data gathered over multiple time points
and/or experimental conditions (Friedman, 2004). However,
due to a limited sample size, large space of possible networks,
and probabilistic equivalence of many alternative models, these
approaches are often unable to find the underlying causal gene
relationships.
Recently, Zhu et al. (2008) showed that supplementing
gene expression profiles with complementary information on
genotypes may help to overcome some of these problems
(Figure S2C). These authors sought to assemble a gene regula-
tory network for the yeast Saccharomyces cerevisiae using
previously published mRNA expression profiles gathered for
112 yeast segregants. Rather than assemble a Bayesian network
from expression data alone, the data were first supplemented
with the genotypes of each segregant. The combined dataset
was then analyzed to identify expression quantitative trait
loci (eQTL)—genetic loci for which different mutant alleles
associate with differences in expression for genes at the same
locus (cis-eQTL) or for genes located elsewhere in the genome
(trans-eQTL). The eQTLs were used as a filter to prioritize
some gene relations and demote others. Any candidate cause-
effect relations in which the effect gene is near an eQTL were
removed, as the cis-eQTL already explains the gene expression
changes at that locus. Conversely, cause-effect relations that
were supported by trans-eQTLs and passed a formal causality
test were prioritized. Supplementing gene expression profiles
with genetic information significantly enhanced the power to
identify bona fide causal gene relationships. Further improve-
ment was achieved by introducing a second filter that prioritized
cause-effect relations that correspond to measured physical
interactions, including data from the many genome-wide chro-
matin immunoprecipitation experiments published for yeast
that document physical interactions between transcription
factors and gene promoters.
Summary
Biology is expanding enormously in its ability to decipher
complex systems. This ability derives from the expanded power
to incorporate diverse and complementary data types and to
inject prior understanding of biological principles. Signal detec-
tion systems such as those discussed here—along with their
filters, integrators, and other components—are leading to funda-
mental new biological discoveries and models, some of which
will ultimately transform our understanding of disease and ther-
apeutics. It is also likely that many of the strategies, technolo-
gies, and computational tools developed for healthcare can beapplied to problems of complexity inherent in other scientific
domains, including energy, agriculture, and the environment.
Healthcare and energy will demand significant societal
resources moving forward—and hence offer unique opportuni-
ties to push the development and application of approaches
for attacking complexity.
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